Literature DB >> 18710603

Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion.

Gary M Brett1, Wendy Hollands, Paul W Needs, Birgit Teucher, Jack R Dainty, Barry D Davis, Jennifer S Brodbelt, Paul A Kroon.   

Abstract

Oranges are rich sources of flavonoids that are bioactive and may protect against age-related diseases. The absorption of orange flavanones may be affected by factors such as processing and subject anthropometric variables, and the bioactivity of the absorbed phytochemicals depends on how they are metabolised during absorption. In a randomised cross-over study, twenty subjects consumed a single portion of orange fruit (150 g) or juice (300 g) that contained the flavanones narirutin and hesperidin, and an additional 109 subjects across a broad age range (18-80 years) consumed the juice. Flavanone metabolites were measured in regularly collected samples of plasma and urine. After consumption of fruit or juice, flavanone conjugates, but not the aglycones, were detected in plasma and urine. The flavanone conjugates were shown to include the 7- and 4'-O-monoglucuronides of naringenin, the 7- and 3'-O-monoglucuronides of hesperetin, two hesperetin diglucuronides and a hesperetin sulfo-glucuronide, but no aglycones or rutinosides. Analysis of the plasma pharmacokinetic and urinary excretion data on a dose-adjusted basis indicated no difference in absorption or excretion of either flavanone between the fruit and juice matrices. In the extended urinary excretion dataset the individual variation was very large (range 0-59 % urinary yield). There was a small but significant (P < 0.05) decrease in the excretion of hesperetin (but not naringenin) with increasing age (P < 0.05), but the effects of sex, BMI and contraceptive pill use were shown not to be associated with the variation in flavanone excretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18710603      PMCID: PMC3508427          DOI: 10.1017/S000711450803081X

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  50 in total

1.  Action of bioflavonoids on inflammation.

Authors:  E SALGADO; D M GREEN
Journal:  J Appl Physiol       Date:  1956-05       Impact factor: 3.531

2.  Prospective study of fruits and vegetables and risk of oral premalignant lesions in men.

Authors:  Nancy Nairi Maserejian; Edward Giovannucci; Bernard Rosner; Athanasios Zavras; Kaumudi Joshipura
Journal:  Am J Epidemiol       Date:  2006-07-17       Impact factor: 4.897

3.  Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area.

Authors:  June M Chan; Furong Wang; Elizabeth A Holly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

4.  Substrate (aglycone) specificity of human cytosolic beta-glucosidase.

Authors:  Jean-Guy Berrin; Mirjam Czjzek; Paul A Kroon; W Russell McLauchlan; Antoine Puigserver; Gary Williamson; Nathalie Juge
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

5.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

6.  Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans.

Authors:  Kitti Németh; Geoff W Plumb; Jean-Guy Berrin; Nathalie Juge; Ralf Jacob; Hassan Y Naim; Gary Williamson; Dallas M Swallow; Paul A Kroon
Journal:  Eur J Nutr       Date:  2003-01       Impact factor: 5.614

Review 7.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.

Authors:  Claudine Manach; Gary Williamson; Christine Morand; Augustin Scalbert; Christian Rémésy
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

8.  Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process.

Authors:  Ching-Huai Ko; Shing-Chuan Shen; Hui-Yi Lin; Wen-Chi Hou; Woan-Ruoh Lee; Ling-Ling Yang; Yen-Chou Chen
Journal:  J Cell Physiol       Date:  2002-10       Impact factor: 6.384

9.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

Authors:  M G Hertog; P C Hollman; M B Katan; D Kromhout
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

10.  Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.

Authors:  Pierangela Totta; Filippo Acconcia; Stefano Leone; Irene Cardillo; Maria Marino
Journal:  IUBMB Life       Date:  2004-08       Impact factor: 3.885

View more
  35 in total

Review 1.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

2.  Regioselectivity of human UDP-glucuronosyltransferase isozymes in flavonoid biotransformation by metal complexation and tandem mass spectrometry.

Authors:  Scott A Robotham; Jennifer S Brodbelt
Journal:  Biochem Pharmacol       Date:  2011-08-30       Impact factor: 5.858

3.  Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial.

Authors:  Candida J Rebello; Robbie A Beyl; Juan J L Lertora; Frank L Greenway; Eric Ravussin; David M Ribnicky; Alexander Poulev; Brandon J Kennedy; Hector F Castro; Shawn R Campagna; Ann A Coulter; Leanne M Redman
Journal:  Diabetes Obes Metab       Date:  2019-09-30       Impact factor: 6.577

4.  Urinary excretion of Citrus flavanones and their major catabolites after consumption of fresh oranges and pasteurized orange juice: A randomized cross-over study.

Authors:  Julian K Aschoff; Ken M Riedl; Jessica L Cooperstone; Josef Högel; Anja Bosy-Westphal; Steven J Schwartz; Reinhold Carle; Ralf M Schweiggert
Journal:  Mol Nutr Food Res       Date:  2016-09-12       Impact factor: 5.914

Review 5.  Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.

Authors:  Maarit J Rein; Mathieu Renouf; Cristina Cruz-Hernandez; Lucas Actis-Goretta; Sagar K Thakkar; Marcia da Silva Pinto
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

6.  The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes.

Authors:  Bradley W Bolling; Michael H Court; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  J Nutr Biochem       Date:  2009-05-14       Impact factor: 6.048

7.  Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.

Authors:  Chenlin Shen; Zhengyue Qian; Ruonan Chen; Xiaoming Meng; Tingting Hu; Zhaolin Chen; Yangyang Li; Cheng Huang; Chaojie Hu; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

8.  Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity.

Authors:  Ana B Cerezo; Mark S Winterbone; Christina W A Moyle; Paul W Needs; Paul A Kroon
Journal:  Mol Nutr Food Res       Date:  2015-09-08       Impact factor: 5.914

9.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

10.  Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.

Authors:  Haiyan Xu; Kaustubh H Kulkarni; Rashim Singh; Zhen Yang; Stephen W J Wang; Vincent H Tam; Ming Hu
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.